Global Experts Meeting On Cell and Gene Therapy

Dubai, UAE   April 25-26, 2018

Call for Abstract

Gene and Cell Therapies have made vital therapeutic advances in under three decades. Inside this brief span traverse, both gene and cell treatments have investigated numerous ideas, created different innovations, surveyed the advances in various animal models, and tried the novel treatments in numerous human clinical trials of dreaded infections. Some energizing changes have been seen in a few infections by the medications. Although a few trials did not give the hope for advancements, every trial has propelled our comprehension of the complex interactions between various tissues and highlighted challenges for further research.

  • Track 1-1: Human Gene Therapy
  • Track 1-2: Stem cell therapy
  • Track 1-3: Human gene therapy
  • Track 1-4: Skin cell therapy
  • Track 1-5: Gene therapy for malignant melanoma
  • Track 1-6: Applications

Inherited metabolic disorders are hereditary conditions that result in digestion issues. Many people with inherited metabolic disorder have an inadequate quality that outcomes in enzyme deficiency. There are many distinctive hereditary metabolic issue, and their side effects, medications, and prognoses fluctuate generally. Inborn error metabolism are uncommon genetic (acquired) disorder in which the body can't legitimately transform food into energy. The disorders are typically brought on by defects in particular proteins (compounds) that help separate (utilize) parts of food. Limited medicines are accessible for inherited metabolic disorders. The essential genetic defect creating the condition can't be remedied with current innovation. Rather, medicines attempt to work around the issue with metabolism.

  • Track 2-1: Causes
  • Track 2-2: Types
  • Track 2-3: Symptoms
  • Track 2-4: Treatment
  • Track 2-5: Diagnosis

Hematopoietic stem cell transplantation (HSCT) is the transplantation of multipotent hematopoietic stem cell, generally derived from bone marrow, peripheral blood, or umbilical cord blood. A stem cell transplant is a treatment for a few sorts of disease. For some individuals, transplants can mean a cure, however for a few people, issues can prompt extreme entanglements or even death. Transplants can likewise be hard emotionally. They regularly require being in the healing facility, being confined, and there's a high danger of symptoms. Many of the effects are short-term, however a few issues can continue for quite a long time. This can mean changes in the way you carry on with your life. For a few people it's only for some time, however for others, the changes may be lifelong.

  • Track 3-1: Bone marrow transplant
  • Track 3-2: Immunoisolation of cell transplantation
  • Track 3-3: Stem cell transplant donars
  • Track 3-4: Side effects and risks
  • Track 3-5: Success rate

Genome mapping is to put a gathering of atomic markers onto their particular positions on genome. Atomic markers come in all structures. Genes can be seen as one extraordinary kind of hereditary markers in development of genome maps, and the guide is mapped the same way as any other markers. The nature of hereditary maps is generally reliant upon the two elements, the quantity of hereditary markers on the guide and the span of the mapping populace. The two components are interlinked, and as bigger mapping populace could expand the "determination" of the maps and keep the guide being "soaked".


  • Track 4-1: Genetic recombination and gene mapping
  • Track 4-2: Gene mapping techniques
  • Track 4-3: Integration with genetic maps
  • Track 4-4: Importance of gene maps

Tissue Science and Engineering utilizes physical, chemical, and biological factors to supplant or potentially enhance natural elements of the phone. Tissue engineering includes the utilization of a platform for the development of new viable tissue for a medicinal reason. While it was once classified as a sub-field of biomaterials, having developed in scope and significance it can be considered as a field in its own. Frequently, the tissues included require certain mechanical and structural properties for appropriate working. The term has likewise been connected to efforts to perform particular biochemical functions utilizing cells inside an artificially-created support system (e.g. an artificial pancreas, or a bio artificial liver). Regenerative medicine is the recent advancement in tissue science and engineering.

  • Track 5-1: Tissue engineering science
  • Track 5-2: Degenerative disorders
  • Track 5-3: Apotosis
  • Track 5-4: Cellular Tissue and Signalling
  • Track 5-5: Tissue culture and scaffolds
  • Track 5-6: Tissue histology

Regenerative medication is the branch of medicine that creates techniques to regrow, repair or replace damaged or unhealthy cells, organs or tissues. Regenerative medicine incorporates the era and utilization of restorative stem cells, tissue engineering and the generation and use of therapeutic stem cells. The promising field of Regenerative Medicine is attempting to restore structure and function of harmed tissues and organs. It is likewise attempting to make solutions for organs that turn out to be permanently damaged. The objective of this medicine is to figure out how to cure already untreatable wounds and sicknesses. In stem cell therapy, or regenerative drug, specialists think about how stem cells might be utilized to supplant, repair, reprogram or renew your sick cells. stem cells can develop and form into different cell types in our body.

  • Track 6-1: Regenerative cell therapy
  • Track 6-2: Stem cells in regenerative medicine
  • Track 6-3: New tools and technologies
  • Track 6-4: Regenerative medicine future

Genomics is an interdisciplinary field of science concentrating on genomes. Genome altering, or genome editing with engineered nucleases (GEEN) is a kind of hereditary building in which DNA is embedded, erased or supplanted in the genome of a living creature utilizing built nucleases, or "sub-atomic scissors." TALENs are Transcription Activator-Like Effector Nucleases. They are counterfeit confinement catalysts ready to cut DNA just where they experience a particular succession of nucleotides. The story starts with the disclosure of a group of proteins discharged by plant pathogens in the family Xanthomonas. APStock Germ line altering can be utilized to repair a faulty gene in a sperm cell. Be that as it may, the innovation can likewise be utilized to repair an inadequate gene in a sperm or egg cell, or in a developing life that is just a couple days old. In these cases, called germ line altering, the new gene would be passed to future generations. Clustered routinely interspaced short palindromic rehashes (CRISPR, articulated crisper) are sections of prokaryotic DNA containing short, redundant base successions. Every redundancy is trailed by short portions of spacer DNA from past exposures to outside DNA (e.g., an infection or plasmid). Zinc finger nucleases (ZFNs) are a class of built DNA-restricting proteins that encourage focused on altering of the genome by making twofold strand softens up DNA at client indicated areas.

  • Track 7-1: Commercialization of genome editing technologies
  • Track 7-2: Ethical issues in genome editing
  • Track 7-3: Delivery of genome-editing tools
  • Track 7-4: Genomic medicine

Genes encode proteins and proteins manage cell functions. In addition, each step in the stream of data from DNA to RNA to protein gives the cell a potential control point for self  regulating its functions by altering the amount and kind of proteins it produces. Direction of Gene expression incorporates an extensive variety of components that are utilized by cells to increment or lessen the creation of particular gene products (protein or RNA), and is casually named gene regulation. Advanced projects of gene expression are generally seen in science, Virtually any progression of gene expression can be regulated, from transcriptional start, RNA preparing, and post-translational change of a protein. Frequently, one gene regulator controls another in a gene control system. Steps involved in gene expression might be tweaked, from the transcription step to post-translational modification of a protein.

  • Track 8-1: Gene expression steps
  • Track 8-2: Operon structure and its role in gene expression
  • Track 8-3: Principles of gene expression
  • Track 8-4: Genomic imprinting
  • Track 8-5: mRNA splicing

The Head of Formulation and Drug Delivery will assume a key part in guaranteeing the advancement of a stable product that gives sufficient shelf life to guarantee a safe and strong product. Drug delivery systems  (DDS), for example, lipid-or polymer-based nano particles can be intended to enhance the pharmacological and helpful properties of medications controlled parenterally. A hefty portion of the early issues that frustrated the clinical utilizations of particulate DDS have been overcome, with a few DDS plans of anticancer and anti-fungal medications now affirmed for clinical use. Moreover, there is significant enthusiasm for using the upsides of DDS for in-vivo delivery of new medications derived from proteomics or genomics research for their utilization in ligand-focused on therapeutics

  • Track 9-1: Liposomal drug delivery system
  • Track 9-2: Poloxamer
  • Track 9-3: Formulation strategies
  • Track 9-4: Therapeutic nanoparticles

The Division of  Transplantation and Immunogenetics (T&I) performs human leukocyte antigen (HLA) composing, histocompatibility contemplates for organ and stem cell transplants (SCT), and diverse tests identifying with transplantation, personalised medication and immunogenetics. The Division likewise leads research and gives educational and training programs to healthcare professionals. Over the years, the quantity of potential and actual transplant candidates serves by T&I have expanded exponentially. The division keeps on giving quality testing to decide similarity amongst patients and givers. Likewise, to guarantee convenient checking, better coordination and instructive arrangement to patients in organ transplant and SCT patients. Transplant Laboratory Coordination Center was set up in 2012.

  • Track 10-1: HLA typing
  • Track 10-2: Antibody screening
  • Track 10-3: Cross matches
  • Track 10-4: Transplantation immunology
  • Track 10-5: Matching and compatability

Human gene therapy alludes to items that bring hereditary material into a man's DNA to supplant broken or missing hereditary material, hence treating a malady or irregular medicinal condition. Although some cell treatment items have been endorsed, CBER has not yet affirmed any human gene therapy product available to be purchased. There are three sources of donar cells for cell treatment products. 1) the patient's own cells 2) the cells from another person 3) the cells derived from another creatures, for example, pigs, primates, bovines. Cell therapy products can be altered with the assistance of DNA or another nucleic acid so that the pattern of gene expression is changed.

  • Track 13-1: Marketed Products
  • Track 13-2: Regulation of Cell and Gene Therapy Products
  • Track 13-3: Services and Manufacturing practices
  • Track 13-4: Marketing sectors

The utilization of human embryos for research on embryonic stem (ES) cells is presently beat on the moral and political plan in numerous nations. Despite the potential advantage of utilizing human Embryonic Stem cells in the treatment of diseases, their utilization stays dubious due to their beginning from early fetuses.

  • Track 14-1: Cell & gene therapy and ethics
  • Track 14-2: Cell & gene therapy issues
  • Track 14-3: Germline gene therapy controversy

The utilization of human embryos for research on embryonic stem (ES) cells is presently beat on the moral and political plan in numerous nations. Despite the potential advantage of utilizing Human Embryonic Stem cells in the treatment of diseases, their utilization stays dubious due to their beginning from early fetuses.

  • Track 15-1: Orthopaedic applications
  • Track 15-2: MicroRNA replacement therapy
  • Track 15-3: Stem cell research